Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 84Lymphoma, Non-Hodgkin 71Lymphoma 62Lymphoma, Follicular 58Lymphoma, Mantle-Cell 57Lymphoma, Large B-Cell, Diffuse 40Multiple Myeloma 36Hodgkin Disease 30Lymphoma, B-Cell, Marginal Zone 28Recurrence 27Lymphoma, B-Cell 19Leukemia 18Waldenstrom Macroglobulinemia 14Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms, Plasma Cell 8Lymphoma, T-Cell 7Leukemia, Myeloid, Acute 7Burkitt Lymphoma 7Lymphoma, T-Cell, Peripheral 6Leukemia, B-Cell 6Hematologic Neoplasms 6Sezary Syndrome 5Myelodysplastic Syndromes 5Mycosis Fungoides 5Immune System Diseases 5Small Cell Lung Carcinoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Dexamethasone 49Melphalan 29Cyclophosphamide 24Bortezomib 23Filgrastim 18Calcium Dobesilate 18Peripheral Blood Stem Cell Transplantation 16daratumumab 13pomalidomide 10dexamethasone acetate 8Lenalidomide 8ixazomib 6fludarabine phosphate 6dexamethasone 21-phosphate 6venetoclax 5birtamimab 5auricularum 5Whole-Body Irradiation 5Thalidomide 5Mycophenolic Acid 5Granulocyte Colony-Stimulating Factor 5Cyclosporine 5Radiotherapy 4Interferon-alpha 4Etoposide 4Carboplatin 4Busulfan 4sargramostim 3miridesap 3isatuximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Immunoglobulin Light-chain Amyloidosis × Bendamustine Hydrochloride × Clear all
NCT05451771 2025-07-08

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

Columbia University

Phase 1/2 Recruiting
53 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Proteostasis Deficiencies

NCT01222260 2020-03-30

Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis

Columbia University

Phase 2 Completed
40 enrolled 10 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡